BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38574314)

  • 21. Diagnosis and management of soft tissue sarcomas.
    Scoggins CR; Pisters PW
    Adv Surg; 2008; 42():219-28. PubMed ID: 18953820
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of nomograms for prognostication of patients with primary soft tissue sarcomas of the trunk and extremity: report from the Bone and Soft Tissue Tumor Registry in Japan.
    Sekimizu M; Ogura K; Yasunaga H; Matsui H; Tanaka S; Inagaki K; Kawai A
    BMC Cancer; 2019 Jul; 19(1):657. PubMed ID: 31272407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Soft tissue sarcoma and radiation therapy advances, impact on toxicity.
    El-Bared N; Wong P; Wang D
    Curr Treat Options Oncol; 2015 May; 16(5):19. PubMed ID: 25859829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The profile of extremity and trunk soft tissue sarcoma in a tertiary referral center.
    Mahmoud AMA; Mahmoud M; Charaf A; Moneer MM
    J Egypt Natl Canc Inst; 2017 Jun; 29(2):89-94. PubMed ID: 28462849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
    Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
    Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant image-guided helical intensity modulated radiotherapy of extremity sarcomas - a single center experience.
    Peeken JC; Knie C; Kessel KA; Habermehl D; Kampfer S; Dapper H; Devecka M; von Eisenhart-Rothe R; Specht K; Weichert W; Wörtler K; Knebel C; Wilkens JJ; Combs SE
    Radiat Oncol; 2019 Jan; 14(1):2. PubMed ID: 30626408
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does an Algorithmic Approach to Using Brachytherapy and External Beam Radiation Result in Good Function, Local Control Rates, and Low Morbidity in Patients With Extremity Soft Tissue Sarcoma?
    Klein J; Ghasem A; Huntley S; Donaldson N; Keisch M; Conway S
    Clin Orthop Relat Res; 2018 Mar; 476(3):634-644. PubMed ID: 29443850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low rate of function-limiting side effects with high-dose adjuvant radiotherapy in high-grade soft tissue extremity sarcomas: a retrospective single-center analysis over 10 years.
    Koeksal M; van der Hoek M; Scafa D; Koch D; Leitzen C; Schmeel LC; Feldmann G; Strauss A; Koob S; Giordano FA
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):4877-4888. PubMed ID: 36287264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Completely resected recurrent soft tissue sarcoma: primary anatomic site governs outcomes.
    Stojadinovic A; Yeh A; Brennan MF
    J Am Coll Surg; 2002 Apr; 194(4):436-47. PubMed ID: 11949749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical resection margin classifications for high-grade pleomorphic soft tissue sarcomas of the extremity or trunk: definitions of adequate resection margins and recommendations for sampling margins from primary resection specimens.
    Cates MM; Cates JMM
    Mod Pathol; 2019 Oct; 32(10):1421-1433. PubMed ID: 31053757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Role of MRI-Guided Radiotherapy for Soft Tissue Sarcomas.
    Blitzer GC; Yadav P; Morris ZS
    J Clin Med; 2022 Feb; 11(4):. PubMed ID: 35207317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does the addition of chemotherapy to neoadjuvant radiotherapy impact survival in high-risk extremity/trunk soft-tissue sarcoma?
    Chowdhary M; Chowdhary A; Sen N; Zaorsky NG; Patel KR; Wang D
    Cancer; 2019 Nov; 125(21):3801-3809. PubMed ID: 31490546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A rare case of nerve-sheath sarcoma with rhabdomyoblastic differentiation (malignant triton tumor)].
    Malerba M; Garofalo A
    Tumori; 2003; 89(4 Suppl):246-50. PubMed ID: 12903608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of positron emission tomography in localized extremity soft tissue sarcoma treated with neoadjuvant chemotherapy.
    Schuetze SM; Rubin BP; Vernon C; Hawkins DS; Bruckner JD; Conrad EU; Eary JF
    Cancer; 2005 Jan; 103(2):339-48. PubMed ID: 15578712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic index for extremity soft tissue sarcomas with isolated local recurrence.
    Ramanathan RC; A'Hern R; Fisher C; Thomas JM
    Ann Surg Oncol; 2001 May; 8(4):278-89. PubMed ID: 11352300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Postoperative complications and oncologic outcomes after multimodal therapy of localized high risk soft tissue sarcoma.
    Potkrajcic V; Kolbenschlag J; Sachsenmaier S; Daigeler A; Ladurner R; Golf A; Gani C; Zips D; Paulsen F; Eckert F
    Radiat Oncol; 2022 Dec; 17(1):210. PubMed ID: 36544149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical Resection Margin Classifications for High-grade Pleomorphic Soft Tissue Sarcomas of the Extremity or Trunk After Neoadjuvant Cytotoxic Therapy.
    Cates VM; Cates JMM
    Am J Surg Pathol; 2019 Jun; 43(6):844-850. PubMed ID: 30932925
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Management of soft tissue sarcomas in first isolated local recurrence: a retrospective study of 83 cases].
    Moureau-Zabotto L; Thomas L; Bui BN; Chevreau C; Stockle E; Martel P; Bonneviale P; Marques B; Coindre JM; Kantor G; Matsuda T; Delannes M
    Cancer Radiother; 2004 Oct; 8(5):279-87. PubMed ID: 15561593
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soft tissue tumors of the abdominal wall: analysis of disease patterns and treatment.
    Stojadinovic A; Hoos A; Karpoff HM; Leung DH; Antonescu CR; Brennan MF; Lewis JJ
    Arch Surg; 2001 Jan; 136(1):70-9. PubMed ID: 11146782
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial.
    Pasquali S; Pizzamiglio S; Touati N; Litiere S; Marreaud S; Kasper B; Gelderblom H; Stacchiotti S; Judson I; Dei Tos AP; Verderio P; Casali PG; Woll PJ; Gronchi A;
    Eur J Cancer; 2019 Mar; 109():51-60. PubMed ID: 30690293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.